Organon & Stock News

Beddow Capital Management Inc. lifted its position in Organon & Co. (NYSE:OGN) by 70.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,645 shares of the company’s stock after acquiring an additional 39,662 shares during the quarter. Organon & Co. […]

Carret Asset Management LLC lifted its position in Organon & Co. (NYSE:OGN) by 5.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 91,567 shares of the company’s stock after purchasing an additional 5,099 shares during the quarter. Carret Asset Management LLC’s holdings […]

STOCKHOLM SWEDEN - December 13, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the previously announced transaction, in which the global pharmaceutical company Organo…

STOCKHOLM SWEDEN December 13, 2021. Karolinska Development AB (Nasdaq Stockholm: KDEV) announces today that the previously announced transaction, in which the global pharmaceutical company Organon & Co. (NYSE:OGN) acquires Karolinska Development''s portfolio company Forendo Pharma, has now been completed. This is one of the largest commercial deals in the Nordic biotech sector in 2021.

Expands women''s health pipeline with novel candidates targeting endometriosis and polycystic ovarian syndrome (PCOS) Organon (NYSE: OGN), a global women''s healthcare company, today announced the c…

JERSEY CITY, N.J.--(BUSINESS WIRE)-- #Endometriosis--Organon Announces Close of Forendo Pharma

Virginia Retirement Systems ET AL cut its position in shares of Organon & Co. (NYSE:OGN) by 50.6% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 24,900 shares of the company’s stock after selling 25,519 shares during the period. Virginia Retirement Systems […]

Organon fell after posting quarterly results.

Balasa Dinverno & Foltz LLC purchased a new stake in shares of Organon & Co. (NYSE:OGN) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 27,845 shares of the companys stock, valued at approximately $913,000. A number of other large investors have []

Related Stocks: LMT , OGN , TSN , BTI , BUD , C ,

Sector ETF report for XPH

AdvisorNet Financial Inc purchased a new stake in Organon & Co. (NYSE:OGN) during the third quarter, HoldingsChannel.com reports. The firm purchased 1,609 shares of the companys stock, valued at approximately $53,000. Several other hedge funds also recently bought and sold shares of OGN. State of Alaska Department of Revenue acquired a new position in shares []

Deroy & Devereaux Private Investment Counsel Inc. increased its stake in shares of Organon & Co. (NYSE:OGN) by 32.3% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 613,274 shares of the companys stock after acquiring an additional 149,839 shares during the quarter. []

Organon & Co. (OGN) CEO Kevin Ali at 4th Annual Evercore ISI HealthCONx Conference (Transcript)